Katherine Ellingson

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 787 citations · Full text

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · New England Journal of Medicine · 2021 · 519 citations · Full text

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021

Ashley Fowlkes, Manjusha Gaglani, Kimberly Groover et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 307 citations · Full text

Covid-19 Vaccines, Covid-19 Epidemiology, Vaccine Hesitancy +20

Continued decline in blood collection and transfusion in the <scp>U</scp>nited <scp>S</scp>tates–2015

Katherine Ellingson, Mathew R. P. Sapiano, Kathryn A. Haass et al. · Transfusion · 2017 · 269 citations · Full text

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley Fowlkes, Sarang K. Yoon, Karen Lutrick et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 182 citations · Full text